Skip to main content

SB 642 — Virginia

Health insurance; coverage of medications prescribed for treatment of cancer & diseases of blood.

Passed one chamber 2027 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Health insurance; treatment of cancer and certain diseases; coverage of certain medications. Requires an insurer, corporation providing preferred provider subscription contracts, or health maintenance organization that provides coverage for drugs approved by the Food and Drug Administration and prescribed for the treatment of cancer or diseases of the blood to allow, at the patient's direction, (i) provider-administered drugs for such treatment to be dispensed by an in-network treating provider consistent with a provider agreement; (ii) provider-administered drugs for such treatment to be dispensed by an in-network treating provider when there is a documented delay of at least three days in the delivery of a medication from the designated specialty pharmacy; and (iii) self-administered drugs for such treatment to be sent to the pharmacy of the patient's choosing.

Official abstract, as published by the legislature.

  • SB 642 is a bill in the Virginia Senate, 2027 session, introduced January 14, 2026.
  • Sponsored by Todd E. Pillion, with 1 cosponsor.
  • Current status: passed one chamber.
  • Most recent action (July 21, 2026): Continued from last session.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Todd E. Pillion

Cosponsors (1): Mamie E. Locke

History

  1. Introduced, completed
  2. Passed Senate, completed
  3. Passed House of Delegates, in progress
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Prefiled and ordered printed; Offered 01-14-2026 26105211D Milestone
  2. Senate Referred to Committee on Commerce and Labor
  3. Senate Reported from Commerce and Labor with substitute (15-Y 0-N)
  4. Senate Senate committee offered
  5. Senate Committee substitute printed 26106270D-S1
  6. Senate Rules suspended
  7. Senate Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
  8. Senate Passed by for the day Block Vote (Voice Vote)
  9. Senate Passed by for the day
  10. Senate Read second time
  11. Senate Commerce and Labor Substitute agreed to
  12. Senate Motion to rerefer to Finance and Appropriations agreed to
  13. Senate Rereferred to Finance and Appropriations
  14. Senate Fiscal Impact Statement from Department of Planning and Budget (SB642)
  15. Senate Reported from Finance and Appropriations with substitute (15-Y 0-N)
  16. Senate Committee substitute printed 26107336D-S2
  17. Senate Read second time
  18. Senate Committee substitute reconsidered
  19. Senate Commerce and Labor Substitute rejected
  20. Senate Finance and Appropriations Substitute agreed to
  21. Senate Engrossed by Senate - committee substitute (Voice Vote)
  22. Senate Read third time and passed Senate (40-Y 0-N 0-A) Milestone
  23. House of Delegates Placed on Calendar
  24. House of Delegates Read first time
  25. House of Delegates Referred to Committee on Health and Human Services
  26. Senate Fiscal Impact Statement from Department of Planning and Budget (SB642)
  27. House of Delegates Referred from Health and Human Services and referred to Labor and Commerce (Voice Vote)
  28. House of Delegates Assigned HCL sub: Subcommittee #1
  29. House of Delegates Subcommittee recommends reporting and referring to Appropriations (8-Y 0-N)
  30. House of Delegates Reported from Labor and Commerce and referred to Appropriations (18-Y 3-N)
  31. House of Delegates Assigned HAPP sub: Compensation and Retirement
  32. House of Delegates Continued to next session in Appropriations (Voice Vote)
  33. House of Delegates Continued from last session Latest

Source: Open States. Last checked November 1, 2026. How we keep this accurate ›